Where Do We Stand With the Pfizer Vaccine?
On Monday, November 9, BioNTech, a biotech company owned by a Turkish-German couple, Dr. Ugur Sahin and Ozlem Tureci, together with pharmaceutical giant Pfizer shared some promising news in the wake of the intense race toward eradicating COVID-19. The preliminary but potentially conclusive results of the trial of the mRNA vaccine against the novel coronavirus have sparked flickers of hope around the world. If successful, this will be the world’s first-ever mRNA vaccine. Out of 11 vaccines currently in late-stage trials, only one other company, Moderna, is developing mRNA vaccines against COVID-19, announcing on November 16 that its vaccine also comes with a 94.5% efficacy rate.
